GlassScriptPhysician profile
William S Woolverton
NPI 1679579015
$5,272.70
in general payments reported to CMS, 2019-2025
35 companies · $441 in 2025
The $441 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $982 · 2020: $354 · 2021: $225 · 2022: $1,275 · 2023: $1,283 · 2024: $712 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,436.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,027.37 | 2019-2025 | Latitude Communicator Power Supply, Rotablator Rotational Atherectomy System Console Kit, General - Therapies |
| Biotronik INC. | $606.85 | 2019-2025 | Amvia Edge |
| Janssen Pharmaceuticals, INC | $577.94 | 2019-2024 | Xarelto |
| Abbott Laboratories | $445.38 | 2019-2024 | Mitraclip |
| Novartis Pharmaceuticals Corporation | $274.16 | 2021-2025 | |
| Amgen INC. | $259.08 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $239.95 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $193.24 | 2019-2023 | Farxiga |
| Inari Medical, INC. | $171.33 | 2022 | |
| Kestra Medical Technology Services, INC. | $169.89 | 2022-2023 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $136.58 | 2019-2025 | Eliquis, Camzyos |
| Pfizer INC. | $132.09 | 2019-2023 | |
| Penumbra, INC. | $123.80 | 2019 | |
| Merck Sharp & Dohme LLC | $98.91 | 2021-2023 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $94.04 | 2019-2023 | Evkeeza |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $86.23 | 2023-2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $75.72 | 2019 | |
| Elutia, INC. | $66.87 | 2023 | |
| Alnylam Pharmaceuticals INC. | $63.76 | 2022-2025 | Onpattro |
| Medtronic, INC. | $50.82 | 2023 | Mycarelink |
| Cardiovascular Systems INC. | $45.45 | 2022 | |
| Abiomed | $41.39 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.33 | 2019-2023 | Jardiance |
| Philips North America LLC | $39.35 | 2022 | |
| Terumo Medical Corporation | $38.63 | 2020 | |
| Astellas Pharma US INC | $28.69 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.48 | 2022 | |
| Baxter Healthcare | $19.65 | 2023 | Hillrom - Abpm 7100 Ambulatory Blood Pressure Monitor |
| Impulse Dynamics (USA) INC. | $18.61 | 2024 | Optimizer |
| Cashflow Solutions, LLC | $18.41 | 2023 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Irhythm Technologies, INC. | $17.29 | 2022 | |
| Novo Nordisk INC | $13.71 | 2024 | Wegovy |
| Cleerly, INC. | $13.61 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Preventice Services, LLC | $11.86 | 2020 | |
| G Medical Diagnostic Services, INC. | $6.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Woolverton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.